These limitations highlight the need for further research with larger sample sizes, rigorous study designs, and long-term follow-up to confirm the role of SPB in these specific cardiac arrhythmias and establish its clinical significance. The gene discussed is SFTPB; the disease is cardiac arrhythmia.